Search results for: Novel AI

To help you quickly find what you're looking for, the following filters will help refine your search:

Filter By:

A New Incentive in the Battle Against Mosquito-Borne Diseases: Vector Expedited Review Voucher (VERV)

VIDEO: A New Incentive in the Battle Against Mosquito-Borne Diseases: Vector Expedited Review Voucher (VERV)

29 October 2021

[embed]https://vimeo.com/703724607[/embed] The Vector Expedited Review Voucher (VERV), modelled on the already established US Priority Review Voucher (PRV) for drug development,…

Novel Mosquito Net Marks Breakthrough in New LLINs

17 November 2016

A novel mosquito net that combines the pyrrole chlorfenapyr and the pyrethroid alpha-cypermethrin represents a breakthrough in the development of…

UKAID Support New Anti-Malaria Insecticide Development

11 September 2013

IVCC receives £12 million from the UK Department for International Development (DfID) to develop the next generation of public health…

IVCC supports Good Laboratory Practice certification for field trial sites in Africa

27 September 2023

IVCC is excited to share the news that two more of our collaborating trials facilities in Africa have been granted…

OTHER RESULTS

IVCC at the 9th PAMCA Annual Conference and Exhibition – Ethiopia 2023

18 September 2023

IVCC is delighted to take part in the Annual Conference of the Pan African Mosquito Association (PAMCA) in Adis Ababa, Ethiopia, from…

World Malaria Day 2023

25 April 2023

Today, April 25th, we recognise World Malaria Day. It is an occasion to highlight the impact that this disease has…

WHO issues policy recommendation for new type of insecticide treated nets – an important milestone for malaria prevention tools

20 March 2023

IVCC is delighted to announce that WHO-GMP has issued a policy recommendation for pyrethroid-chlorfenapyr nets to be deployed for malaria…

IVCC congratulates Mitsui Chemicals Agro on the WHO prequalification of VECTRON™ T500

15 March 2023

Press release - date issued 15th March 2023. IVCC is delighted to share the news that the VECTRON™ T500, a…

Evidence base to support a WHO policy recommendation for Interceptor® G2 grows

25 January 2023

IVCC welcomes the publication in The Lancet of the 24-month results of an epidemiological trial in Benin, to assess the public health…

1 2 3 … 5